Interim Management Statement January – September 2020
Third quarter 2020 · Net sales amounted to SEK 132.0 million (167.1), a decrease of 21% (excluding foreign exchange effects, -17%). · Product sales, net sales excluding royalty revenues, amounted to SEK 125.7 million (161.9), a decrease of 22% (excluding foreign exchange effects, -18%). · Net sales in the Paediatrics segment reached SEK 101.9 million (128.0), a decrease of 20%. · Net sales in the Adult Health segment amounted to SEK 29.3 million (38.8) a decrease of 24%. · Operating expenses amounted to SEK 62.5 million (72.5), a decrease of 14%. · Operating profit